Bristol Myers Squibb Co: director Phyllis R Yale received 560.897 shares

What happened Phyllis R Yale, a director, received 560.897 deferred share units (award/grant) on Sep 30, 2026 at a price of $62.40 per unit, for a reported value of $35,000. The instrument is a derivative (deferred share units that will convert into common stock on settlement).

Key details

• Transaction date and price: Sep 30, 2026 at $62.40 per unit.
• Shares/units received: 560.897 deferred share units, reported value $35,000.
• Shares owned after the transaction: not reported in the filing.
• Filing date: Oct 2, 2026.
• Footnotes:
  • F1: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.
  • F2: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors.

Why it may matter This Form 4 reports an award of deferred share units that are derivative securities which will convert into common stock upon settlement per the footnote. A filing does not show why the insider traded or why the company acted.